Delivery Order SPE2DE24DA010-SPE2D625F2AEZ
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350.00 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The contract, which involves no set-aside designation and therefore represents full and open competition, is for the delivery of the Aveir Leadless Pacemaker system to be performed at the contractor's facility in Santa Clara,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $28,350 fixed-price delivery order with economic price adjustment for the supply of Aveir Leadless Pacemakers. The award, issued on June 4, 2025, is set to conclude by June 10, 2025, and represents a child contract under Abbott Laboratories Inc.'s parent entity. The contract was awarded without set-aside designation, indicating full and open competition, and will be performed in Santa Clara, California. The...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $29.7K fixed-price delivery order with economic price adjustment authority for the AVEIR leadless pacemaker system. The award, issued on June 18, 2025, with an ultimate completion date of June 24, 2025, represents a child contract under Abbott's broader relationship with the Defense Logistics Agency's Medical Supply Chain. The contract involves delivery to Santa Clara, California, and was awarded through full...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $49.8K by the Department of Defense's Medical Supply Chain for the delivery of Aveir Leadless Pacemakers. The contract, awarded on August 1, 2025, with an ultimate completion date of August 6, 2025, will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition. The award represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $9,500 fixed-price delivery order with economic price adjustment for the AVEIR leadless pacemaker system on September 12, 2025. The contract, issued by the Defense Logistics Agency's Medical Supply Chain organization, will be performed in Santa Clara, California, with an ultimate completion date of September 17, 2025. This delivery order was awarded without a set-aside designation, indicating full and open...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $18,600 fixed-price delivery order with economic price adjustment for Aveir Leadless Pacemakers, with an ultimate completion date of July 23, 2025. The contract was awarded without a set-aside designation on July 18, 2025, indicating full and open competition. Performance will take place in Santa Clara, California, with funding provided by the Defense Logistics Agency's Medical Supply Chain division, which...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $14,850 by the Department of Defense's Medical Supply Chain on July 24, 2025, with an ultimate completion date of July 29, 2025. The contract is for the AVEIR product line and will be performed in Santa Clara, California. This delivery order was issued without a set-aside designation, indicating full and open competition. The award represents a task order under Abbott's broader...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $9,500 fixed-price delivery order (Contract No. 4569453256) for AVEIR products by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025, with an ultimate completion date of September 17, 2025. The work will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition among qualified vendors. Abbott Vascular has...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F2AEZDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350 by the Defense Logistics Agency's Medical Supply Chain on August 26, 2025, with an ultimate completion date of August 29, 2025. The contract, which was not set-aside and available through full and open competition, is for the delivery of Aveir Leadless Pacemakers to be performed at Abbott's location in Santa Clara, California. This delivery order represents a continuation of Abbott Vascular's established role as a critical supplier of advanced cardiovascular medical technologies to federal defense healthcare systems, building upon the company's substantial Indefinite Delivery Contract portfolio with the DLA valued at over $117 million for comprehensive procedural packages and cardiovascular technologies. The fixed-price contract with economic price adjustment provisions reflects the Defense Logistics Agency's procurement of specialized medical devices to support federal healthcare operations. Abbott Vascular Inc. has demonstrated significant capabilities in this domain through numerous prior awards for sophisticated cardiovascular devices including stents, pacemakers, heart valves, and implantable cardiac monitors. This relatively modest delivery order serves as an incremental task under the broader framework of the agency's medical supply chain operations, leveraging established vendor relationships and contract vehicles to efficiently procure critical medical equipment for defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 8/26/25 |